Atea Pharmaceuticals, Inc. - Common Stock (AVIR)
CUSIP: 04683R106
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 78,888,889
- Total 13F shares
- 53,140,830
- Share change
- +445,219
- Total reported value
- $154,099,223
- Put/Call ratio
- 181%
- Price per share
- $2.90
- Number of holders
- 112
- Value change
- +$874,820
- Number of buys
- 44
- Number of sells
- 45
Quarterly Holders Quick Answers
What is CUSIP 04683R106?
CUSIP 04683R106 identifies AVIR - Atea Pharmaceuticals, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 04683R106:
Institutional Holders of Atea Pharmaceuticals, Inc. - Common Stock (AVIR) as of Q3 2025
As of 30 Sep 2025,
Atea Pharmaceuticals, Inc. - Common Stock (AVIR) was held by
112 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
53,140,830 shares.
The largest 10 holders included
BlackRock, Inc., BML Capital Management, LLC, FMR LLC, TANG CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, Bain Capital Life Sciences Investors, LLC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
112
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
105
Q3 2025 holders
112
Holder diff
7
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.